EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue

Wushan T. Jayalath, Medha J. Gunaratna, Chamila C. Kadigamuwa, Charitha Thambiliyagodage, Jayangika N. Dahanayake

Applied Biosciences · 10.08.2026 · 5 (3) · 69

DOI: 10.3390/applbiosci5030069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biosciences, online erschienen am 10.08.2026. Verfasst von Wushan T. Jayalath und 4 weiteren Autor:innen. Die Arbeit nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Organization for Women in Science for the Developing World, UNESCO-TWAS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, over 55 million people are affected by Alzheimer’s disease (AD), a number that is increasing rapidly and projected to triple by 2050. AD is a type of neurodegenerative disorder for which there is no curative treatment. The accumulation of amyloid-β (Aβ) plaques and the formation of neurofibrillary tangles are the hallmarks of AD. Curcumin, a bioactive compound extracted from turmeric rhizomes, has shown significant neuroprotective properties, including anti-amyloidogenic, anti-inflammatory, antioxidant, and metal-chelating. Though much research has revealed the potential of curcumin as a promising therapeutic agent for AD, the limited bioavailability of curcumin restricts its effectiveness in pharmaceutical applications. To overcome this challenge, nanocarrier-based delivery systems have emerged as a promising strategy for enhancing the bioavailability and therapeutic efficacy of curcumin. This review provides an overview of recent findings on curcumin-based nanocarriers for AD therapy.

Förderung

  • Organization for Women in Science for the Developing World
  • UNESCO-TWAS

Zitieren

APA

Jayalath, W. T., Gunaratna, M. J., Kadigamuwa, C. C., Thambiliyagodage, C., & Dahanayake, J. N. (2026). Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue. Applied Biosciences, 5(3), 69. https://doi.org/10.3390/applbiosci5030069

Vancouver

Jayalath WT, Gunaratna MJ, Kadigamuwa CC, Thambiliyagodage C, Dahanayake JN. Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue. Applied Biosciences. 2026;5(3):69. doi:10.3390/applbiosci5030069

BibTeX
@article{Jayalath2026,
  author = {Jayalath, Wushan T. and Gunaratna, Medha J. and Kadigamuwa, Chamila C. and Thambiliyagodage, Charitha and Dahanayake, Jayangika N.},
  title = {Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue},
  journal = {Applied Biosciences},
  year = {2026},
  volume = {5},
  number = {3},
  pages = {69},
  doi = {10.3390/applbiosci5030069}
}
Kostenlos starten →